ONCOLOGY-NY 润色咨询

ONCOLOGY-NEW YORK

出版年份：1987 年文章数：21 投稿命中率： 开通期刊会员，数据随心看

出版周期：Monthly 自引率：1.1% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=1096263, encodeId=4765109626338, content=两个IF相当的期刊，如何选择要投哪个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096264, encodeId=a348109626421, content=选刊时有什么原则吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=497513, encodeId=11ab49e513a2, content=跨过2分了，明年会不会再略冲冲，很有希望, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=459, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=pingjian888, createdTime=Mon Jul 01 11:36:00 CST 2013, time=2013-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=473872, encodeId=89854e387239, content=偏重的研究方向：肿瘤;癌症;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=517, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Feb 23 10:43:00 CST 2011, time=2011-02-23, status=1, ipAttribution=)]
    2021-12-29 衣谷

    两个IF相当的期刊，如何选择要投哪个？

    1

    展开1条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=1096263, encodeId=4765109626338, content=两个IF相当的期刊，如何选择要投哪个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096264, encodeId=a348109626421, content=选刊时有什么原则吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=497513, encodeId=11ab49e513a2, content=跨过2分了，明年会不会再略冲冲，很有希望, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=459, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=pingjian888, createdTime=Mon Jul 01 11:36:00 CST 2013, time=2013-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=473872, encodeId=89854e387239, content=偏重的研究方向：肿瘤;癌症;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=517, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Feb 23 10:43:00 CST 2011, time=2011-02-23, status=1, ipAttribution=)]
    2021-12-28 学医的彭于晏

    选刊时有什么原则吗？

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=1096263, encodeId=4765109626338, content=两个IF相当的期刊，如何选择要投哪个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096264, encodeId=a348109626421, content=选刊时有什么原则吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=497513, encodeId=11ab49e513a2, content=跨过2分了，明年会不会再略冲冲，很有希望, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=459, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=pingjian888, createdTime=Mon Jul 01 11:36:00 CST 2013, time=2013-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=473872, encodeId=89854e387239, content=偏重的研究方向：肿瘤;癌症;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=517, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Feb 23 10:43:00 CST 2011, time=2011-02-23, status=1, ipAttribution=)]
    2013-07-01 pingjian888

    跨过2分了，明年会不会再略冲冲，很有希望

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1096263, encodeId=4765109626338, content=两个IF相当的期刊，如何选择要投哪个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096264, encodeId=a348109626421, content=选刊时有什么原则吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=497513, encodeId=11ab49e513a2, content=跨过2分了，明年会不会再略冲冲，很有希望, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=459, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=pingjian888, createdTime=Mon Jul 01 11:36:00 CST 2013, time=2013-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=473872, encodeId=89854e387239, content=偏重的研究方向：肿瘤;癌症;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=517, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Feb 23 10:43:00 CST 2011, time=2011-02-23, status=1, ipAttribution=)]
    2011-02-23 匿名用户

    偏重的研究方向：肿瘤;癌症;

    0

共7条页码: 1/1页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分